1.
The fragility of phase 3 trials supporting FDA-approved anticancer medicines: a retrospective analysis
by Del Paggio, Joseph C, MD
The lancet oncology, 2019, Vol.20 (8), p.1065-1069

2.
Delivery of meaningful cancer care: a retrospective cohort study assessing cost and benefit with the ASCO and ESMO frameworks
by Del Paggio, Joseph C, MD
The lancet oncology, 2017, Vol.18 (7), p.887-894
